Interleukin-2 reverses the ability of cyclosporine to induce tolerance to class I disparate kidney allografts in miniature swine.
Fishbein
J M
JM
Transplantation Biology Research Center, Massachusetts General Hospital, Charlestown 02129.
Gianello
P
P
Nickeleit
V
V
Vitiello
D
D
Blancho
G
G
Latinne
D
D
Nakajima
K
K
Rosengard
B
B
Colvin
R
R
Sachs
D H
DH
D000818:Animals; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D006084:Graft Rejection / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006650:Histocompatibility Testing; D007108:Immune Tolerance; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007165:Immunosuppression Therapy; D007376:Interleukin-2 / Q000494:pharmacology*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D013552:Swine; D013556:Swine, Miniature; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology
D015395:Histocompatibility Antigens Class I; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007376:Interleukin-2; D016572:Cyclosporine; D003404:Creatinine